Arnold G. Vulto
- Immunology top 2%
- Economics and Econometrics top 0.5%
- Pediatrics, Perinatology and Child Health top 0.5%
- Pharmacology top 0.1%
- Oncology top 2%
- Co-authors
- Steven SimoensJ. AartsMaarten J. ten BergTeun van GelderIsabelle HuysPieter DylstRon A. A. MathôtLoes E. Visser
- Topics
- Pharmaceutical Economics and Policy (64 papers)Biosimilars and Bioanalytical Methods (64 papers)Health Systems, Economic Evaluations, Quality of Life (50 papers)
- Journals
- SHILAP Revista de lepidopterologíaNature BiotechnologyPEDIATRICS
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
Arnold G. Vulto
223 papers receiving 7.6k citations
Hit Papers
Peers
Comparison fields: 5 of 174
- Immunology 1.5k
- Economics and Econometrics 1.2k
- Pediatrics, Perinatology and Child Health 1.2k
- Pharmacology 1.1k
- Oncology 1.1k
Countries citing papers authored by Arnold G. Vulto
This map shows the geographic impact of Arnold G. Vulto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold G. Vulto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold G. Vulto more than expected).
Fields of papers citing papers by Arnold G. Vulto
This network shows the impact of papers produced by Arnold G. Vulto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold G. Vulto. The network helps show where Arnold G. Vulto may publish in the future.
Co-authorship network of co-authors of Arnold G. Vulto
This figure shows the co-authorship network connecting the top 25 collaborators of Arnold G. Vulto. A scholar is included among the top collaborators of Arnold G. Vulto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnold G. Vulto. Arnold G. Vulto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM:A Phase I Clinical Trial Including Correlative Studies | 67 |
| 3 | 12 | |
| 4 | 17 | |
| 5 | 17 | |
| 6 | 16 | |
| 7 | 22 | |
| 8 | 9 | |
| 9 | 32 | |
| 10 | 39 | |
| 11 | 25 | |
| 12 | 23 | |
| 13 | 2 | |
| 14 | 71 | |
| 15 | [Biosimilar registered despite the Netherlands opposing vote: greater uncertainty about authorised drugs in the Netherlands]. | 1 |
| 16 | 0 | |
| 17 | 10 | |
| 18 | 8 | |
| 19 | 46 | |
| 20 | 4 |
About Arnold G. Vulto
Arnold G. Vulto is a scholar working on Transplantation, Immunology and Economics and Econometrics, having authored 227 papers that have together received 7.9k indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (64 papers), Biosimilars and Bioanalytical Methods (64 papers) and Health Systems, Economic Evaluations, Quality of Life (50 papers). The work is most often cited by research in Health Information Management (808 citations), Geriatrics and Gerontology (651 citations) and Transplantation (429 citations). Arnold G. Vulto has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Steven Simoens, J. Aarts, Maarten J. ten Berg, Teun van Gelder, Isabelle Huys, Pieter Dylst, Ron A. A. Mathôt, Loes E. Visser, Albert Hofman and Liese Barbier. Their work appears in journals such as SHILAP Revista de lepidopterología, Nature Biotechnology and PEDIATRICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.